Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

Mar 2021| TBR1142B| TBRC (Publisher)

Report Highlights

Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

Including: The global antisense & RNAi therapeutics market is segmented into -
1) By Technology: RNA Interference; Antisense RNA
2) By Route Of Administration: Intravenous Injections; Intra-Dermal Injections; Other Delivery Methods
3) By Indication: Oncology; Cardiovascular Diseases; Respiratory Disorders; Neurological Disorders; Infectious Diseases; Other Diseases

Covering: Biogen Inc.; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.; Arrowhead Pharmaceuticals, Inc.; Moderna, Inc.; Sanofi S.A.; Dicerna Pharmaceuticals, Inc.

Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the antisense & RNAi therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global antisense & RNAi therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by technology, by route of administration and by indication.
  • Market Characteristics – The market characteristics section of the report defines and explains the antisense and RNAi therapeutics market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global antisense and RNAi therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact Of COVID-19 – This chapter discusses the impact of COVID-19 on the antisense and RNAi therapeutics market.
  • Global Market Size And Growth – This section contains the global historic (2017-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2017-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2017-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2017-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global antisense and RNAi therapeutics market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for antisense and RNAi therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: 1) By Technology: RNA Interference; Antisense RNA

2) By Route Of Administration: Intravenous Injections; Intra-Dermal Injections; Other Delivery Methods
3) By Indication: Oncology; Cardiovascular Diseases; Respiratory Disorders; Neurological Disorders; Infectious Diseases; Other Diseases

Companies Mentioned: Biogen Inc.; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.; Arrowhead Pharmaceuticals, Inc.; Moderna, Inc.; Sanofi S.A.; Dicerna Pharmaceuticals, Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 2 : Global Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 3 : Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 4 : Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 5 : Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 6 : Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 7 : Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 8 : Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 9 : Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 10 : Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 11 : Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 12 : Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 13 : Asia-Pacific Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
  • Table 14 : Asia Pacific Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 15 : Asia-Pacific Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 16 : Asia-Pacific Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 17 : Asia-Pacific Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 18 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 19 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 20 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 21 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 22 : China Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
  • Table 23 : China Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
  • Table 24 : China Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
  • Table 25 : China Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 26 : China Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 27 : China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 28 : China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 29 : China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 30 : China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 31 : India Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
  • Table 32 : India Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
  • Table 33 : India Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
  • Table 34 : India Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 35 : India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 36 : India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 37 : India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 38 : India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 39 : Japan Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
  • Table 40 : Japan Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
  • Table 41 : Japan Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
  • Table 42 : Japan Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 43 : Japan Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 44 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 45 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 46 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 47 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 48 : Australia Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 49 : Australia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 50 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 51 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 52 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 53 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 54 : Indonesia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 55 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 56 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 57 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 58 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 59 : South Korea Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 60 : South Korea Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 61 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 62 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 63 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 64 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 65 : Western Europe Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country2015-2020, $
  • Table 66 : Western Europe Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 67 : Western Europe Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 68 : Western Europe Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 69 : Western Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 70 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 71 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 72 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 73 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 74 : UK Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
  • Table 75 : UK Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
  • Table 76 : UK Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
  • Table 77 : UK Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 78 : UK Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 79 : UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 80 : UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 81 : UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 82 : UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 83 : Germany Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 84 : Germany Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 85 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 86 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 87 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 88 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 89 : France Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 90 : France Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 91 : France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 92 : France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 93 : France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 94 : France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 95 : Eastern Europe Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
  • Table 96 : Eastern Europe Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 97 : Eastern Europe Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 98 : Eastern Europe Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 99 : Eastern Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 100 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 101 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 102 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 103 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 104 : Russia Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 105 : Russia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 106 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 107 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 108 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 109 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 110 : North America Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
  • Table 111 : North America Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 112 : North America Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 113 : North America Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 114 : North America Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 115 : North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 116 : North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 117 : North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 118 : North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 119 : USA Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
  • Table 120 : USA Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
  • Table 121 : USA Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
  • Table 122 : USA Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 123 : USA Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 124 : USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 125 : USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 126 : USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 127 : USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 128 : South America Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
  • Table 129 : South America Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 130 : South America Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 131 : South America Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 132 : South America Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 133 : South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 134 : South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 135 : South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 136 : South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 137 : Brazil Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 138 : Brazil Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 139 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 140 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 141 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 142 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 143 : Middle East Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
  • Table 144 : Middle East Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 145 : Middle East Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 146 : Middle East Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Table 147 : Middle East Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 148 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 149 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 150 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 151 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 152 : Africa Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
  • Table 153 : Africa Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 154 : Africa Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 155 : Africa Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Table 156 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 157 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 158 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Table 159 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, $ Million
  • Table 160 : Global Antisense & RNAi Therapeutics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 161 : Biogen Inc. -Financial Performance, 2015 -2019, $ Million
  • Table 162 : Ionis Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million
  • Table 163 : Alnylam Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million
  • Table 164 : Arrowhead Pharmaceuticals, Inc. -Financial Performance, 2016 -2020, $ Million
  • Table 165 : Moderna, Inc. -Financial Performance, 2016 -2019, $ Million
  • Table 166 : Sanofi S.A. -Financial Performance, 2015 -2019, $ Million
  • Table 167 : Dicerna Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million
  • Table 168 : Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), 2020 -2025, By Country
  • Table 169 : Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Technology, 2020 -2025
  • Table 170 : Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Route of Administration, 2020 -2025
  • Table 171 : Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Indication, 2020 -2025
  • Figure 1 : Global Antisense & RNAi Therapeutics Market Segmentation By Technology
  • Figure 2 : Global Antisense & RNAi Therapeutics Market Segmentation By Route of Administration
  • Figure 3 : Global Antisense & RNAi Therapeutics Market Segmentation By Indication
  • Figure 4 : Global Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 5 : Global Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 6 : Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 7 : Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 8 : Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 9 : Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 10 : Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 11 : Asia-Pacific Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 12 : Asia-Pacific Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 13 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 14 : Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 15 : China Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 16 : China Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 17 : China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 18 : China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 19 : India Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 20 : India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 21 : India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 22 : Japan Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 23 : Japan Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 24 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 25 : Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 26 : Australia Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 27 : Australia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 28 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 29 : Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 30 : Indonesia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 31 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 32 : Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 33 : South Korea Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 34 : South Korea Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 35 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 36 : South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 37 : Western Europe Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 38 : Western Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 39 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 40 : Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 41 : UK Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 42 : UK Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 43 : UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 44 : UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 45 : Germany Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 46 : Germany Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 47 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 48 : Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 49 : France Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 50 : France Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 51 : France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 52 : France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 53 : Eastern Europe Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 54 : Eastern Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 55 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 56 : Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 57 : Russia Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 58 : Russia Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 59 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 60 : Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 61 : North America Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 62 : North America Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 63 : North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 64 : North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 65 : USA Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 66 : USA Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 67 : USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 68 : USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 69 : South America Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 70 : South America Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 71 : South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 72 : South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 73 : Brazil Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 74 : Brazil Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 75 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 76 : Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 77 : Middle East Antisense & RNAi Therapeutics Market, Historic, 2017 -2020, $ Million
  • Figure 78 : Middle East Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 79 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 80 : Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 81 : Africa Antisense & RNAi Therapeutics Market, Forecast, 2020 -2025, 2030F, $ Million
  • Figure 82 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 83 : Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 -2020, 2025F, 2030F, %
  • Figure 84 : Global Antisense & RNAi Therapeutics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 85 : Biogen Inc. -Financial Performance, 2015 -2019, $ Million
  • Figure 86 : Ionis Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million
  • Figure 87 : Alnylam Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million
  • Figure 88 : Arrowhead Pharmaceuticals, Inc. -Financial Performance, 2016 -2020, $ Million
  • Figure 89 : Moderna, Inc. -Financial Performance, 2016 -2019,$ Million
  • Figure 90 : Sanofi S.A. -Financial Performance, 2015 -2019, $ Million
  • Figure 91 : Dicerna Pharmaceuticals, Inc. -Financial Performance, 2015 -2019, $ Million

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report